Immunonutritional therapy by induced gamma delta T cell in patients with cancer chemotherapy
Japan Society for the Promotion of Science:Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C)
Date (from‐to) : 2015/04 -2020/03
Author : Imataki Osamu
Among the lymphocyte fractions in the tumor cells of patients undergoing cancer chemotherapy for hematological malignancies, helper T cells and B cells significantly affected patients’ survival. γδT cells are a very small component in these lymphocyte fractions, and their effects on clinical outcome were not fully analyzed.